Core Viewpoint - Xinda Co., Ltd. reported a decline in revenue for Q3 2025, but a significant increase in net profit, indicating a strong performance in profitability despite lower sales figures [1][2]. Financial Performance - Q3 2025 revenue was 586 million yuan, a decrease of 5.59% year-on-year [2]. - Net profit attributable to shareholders for Q3 2025 was approximately 59.85 million yuan, a substantial increase of 5447.46% year-on-year [1][2]. - For the first three quarters of 2025, total revenue reached 2.008 billion yuan, reflecting a year-on-year growth of 6.11% [1][2]. - Net profit attributable to shareholders for the first three quarters was about 196 million yuan, up 3064.56% year-on-year [1][2]. Product Performance - The main product, Acetochlor, generated sales of 847 million yuan during the reporting period, with an average price of 105,000 yuan per ton, marking a 38.16% increase year-on-year [3]. - The sales volume of the main products closely matched production levels, resulting in stable inventory compared to the end of 2024 [3]. Company Overview - Xinda Co., Ltd. was established in 1999 and went public on the Shanghai Stock Exchange in 2017, focusing on the research, production, and marketing of innovative herbicide raw materials and formulations [3]. - The company operates six wholly-owned subsidiaries in Shandong and Liaoning, with three major production bases and multiple marketing and research centers [3].
先达股份前三季度净利暴增3064%,赚1.96亿元